UNTEPY

Serial Number 97920388
730

Registration Progress

Application Filed
May 4, 2023
Under Examination
Sep 3, 2024
Approved for Publication
Jul 9, 2024
Published for Opposition
Jul 9, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Sep 03, 2025 31 days

Trademark Image

UNTEPY

Basic Information

Serial Number
97920388
Filing Date
May 4, 2023
Published for Opposition
July 9, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Dec 5, 2024
Application
Pending
Classes
005

Rights Holder

Crinetics Pharmaceuticals, Inc.

03
Address
6055 Lusk Blvd.
San Diego, CA 92121

Ownership History

Crinetics Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Crinetics Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Danny M. Awdeh

USPTO Deadlines

Next Deadline
31 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
September 03, 2025
Extension Available
Until September 03, 2025

Application History

27 events
Date Code Type Description Documents
Dec 5, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 5, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 5, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 19, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 31, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 30, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 30, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 30, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 5, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Apr 5, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 5, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 6, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 28, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 28, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 28, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 30, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 9, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 8, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer; all for human use

Classification

International Classes
005